Farxiga (dapagliflozin) is an orally administered, brand-name medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. SGLT2 inhibitors help lower blood sugar by causing the ...

Merck and Pfizer are to take on the crowded SGLT2 inhibitor market with a keenly-priced new contender. The FDA approved Steglatro (ertugliflozin) as a monotherapy in conjunction with diet and ...

Bayer and Merck & Co’s heart failure drug vericiguat has been approved by the FDA under the brand name Verquvo ... AZ’s big rival in the market for SGLT2 inhibitor class drugs.

Farxiga (dapagliflozin) is an orally administered, brand-name medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. SGLT2 inhibitors help lower blood sugar by causing the ...

Last year, the European Medicines Agency also said that research on rodents suggested the artificial hormones packaged in tirzepatide — sold under the brand name Mounjaro — could also increase ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Tailored Brands tapped Whit Alexander as executive vice president and chief customer officer on Tuesday. The retail company runs Men’s Wearhouse, Jos. A. Bank, K and G Fashion Superstore and Moores.

STATESVILLE, N.C., Feb. 10, 2025 /PRNewswire/ -- Momentec Brands is pleased to announce that Christine Rose has joined the company as Chief Technology Officer (CTO). Momentec Brands is a leading ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

sodium-glucose transporter 2 (SGLT2) inhibitors — these reduce the amount of glucose reabsorbed by the kidneys, meaning that it is excreted in the urine. A meta-analysis, published in the ...